US396255A
(en)
*
|
|
1889-01-15 |
|
Atmospheric gas-burner |
DE440337C
(de)
|
1925-09-22 |
1927-01-31 |
Zellstoff Und Papierfabrikatio |
Herstellung von schwefliger Saeure fuer die Sulfitlaugengewinnung
|
US2803582A
(en)
|
1956-07-16 |
1957-08-20 |
Leonid S Cherney |
Local anesthetic composition
|
NL241476A
(xx)
|
1958-07-24 |
|
|
|
US3137631A
(en)
|
1959-12-01 |
1964-06-16 |
Faberge Inc |
Encapsulation in natural products
|
US3216897A
(en)
|
1961-11-02 |
1965-11-09 |
Air Reduction |
Injectable anesthetic
|
US3185625A
(en)
*
|
1961-11-08 |
1965-05-25 |
Brown Ethan Allan |
Injectionable substances
|
DE1792410B2
(de)
|
1967-09-01 |
1980-03-13 |
Apoteksvarucentralen Vitrum Apotekareaktiebolaget, Stockholm |
Arzneimittelzubereitung zur intravenösen Injektion
|
US3981984A
(en)
|
1968-04-01 |
1976-09-21 |
Colorcon Incorporated |
Color film coating of tablets and the like
|
US3594476A
(en)
|
1969-05-12 |
1971-07-20 |
Massachusetts Inst Technology |
Submicron aqueous aerosols containing lecithin
|
US3937668A
(en)
|
1970-07-15 |
1976-02-10 |
Ilse Zolle |
Method for incorporating substances into protein microspheres
|
NL7012832A
(xx)
|
1970-08-29 |
1972-03-02 |
|
|
US3715432A
(en)
|
1971-01-22 |
1973-02-06 |
Massachusetts Inst Technology |
Submicron aqueous aerosols containing lecithin
|
US3794476A
(en)
|
1972-12-26 |
1974-02-26 |
Ppg Industries Inc |
Method for thermally tempering glass sheet by liquid quenching
|
GB1413186A
(en)
|
1973-06-27 |
1975-11-12 |
Toyo Jozo Kk |
Process for encapsulation of medicaments
|
US4798846A
(en)
*
|
1974-03-28 |
1989-01-17 |
Imperial Chemical Industries Plc |
Pharmaceutical compositions
|
GB1472793A
(en)
|
1974-03-28 |
1977-05-04 |
Ici Ltd |
Pharmaceutical compositions
|
US3965255A
(en)
|
1974-05-01 |
1976-06-22 |
E. E. Eljim Ecology Ltd. |
Controlled drug releasing preparations
|
JPS5612114B2
(xx)
|
1974-06-07 |
1981-03-18 |
|
|
GB1502774A
(en)
|
1974-06-25 |
1978-03-01 |
Nat Res Dev |
Immunological preparations
|
CH588887A5
(xx)
|
1974-07-19 |
1977-06-15 |
Battelle Memorial Institute |
|
US4073943A
(en)
|
1974-09-11 |
1978-02-14 |
Apoteksvarucentralen Vitrum Ab |
Method of enhancing the administration of pharmalogically active agents
|
US4107288A
(en)
|
1974-09-18 |
1978-08-15 |
Pharmaceutical Society Of Victoria |
Injectable compositions, nanoparticles useful therein, and process of manufacturing same
|
JPS5186117A
(en)
|
1975-01-27 |
1976-07-28 |
Tanabe Seiyaku Co |
Johoseibiryushiseizainoseiho |
US4006025A
(en)
|
1975-06-06 |
1977-02-01 |
Polaroid Corporation |
Process for dispersing sensitizing dyes
|
JPS5231981A
(en)
|
1975-08-18 |
1977-03-10 |
Takeda Chem Ind Ltd |
Microcapsule preparation method
|
CA1077842A
(en)
|
1975-10-09 |
1980-05-20 |
Minnesota Mining And Manufacturing Company |
Albumin medicament carrier system
|
DE2557615C2
(de)
|
1975-12-20 |
1985-08-14 |
Bayer Ag, 5090 Leverkusen |
Neue Niclosamid-Suspensionsformulierungen
|
GB1523965A
(en)
|
1976-03-19 |
1978-09-06 |
Ici Ltd |
Pharmaceutical compositions containing steroids
|
GB1578776A
(en)
|
1976-06-10 |
1980-11-12 |
Univ Illinois |
Hemoglobin liposome and method of making the same
|
US4078052A
(en)
|
1976-06-30 |
1978-03-07 |
The United States Of America As Represented By The Secretary Of Health, Education And Welfare |
Large unilamellar vesicles (LUV) and method of preparing same
|
GB1548022A
(en)
|
1976-10-06 |
1979-07-04 |
Wyeth John & Brother Ltd |
Pharmaceutial dosage forms
|
US4086257A
(en)
|
1976-10-12 |
1978-04-25 |
Sears Barry D |
Phosphatidyl quaternary ammonium compounds
|
US4320121A
(en)
|
1976-10-12 |
1982-03-16 |
Sears Barry D |
Method of emulsifying cholesterol, cholesterol esters and triglyceride compounds
|
US4351831A
(en)
|
1977-11-02 |
1982-09-28 |
Massachusetts Institute Of Technology |
Process and composition for treating disorders by administering isoxsurpine and choline
|
US4356167A
(en)
|
1978-01-27 |
1982-10-26 |
Sandoz, Inc. |
Liposome drug delivery systems
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
US4529561A
(en)
|
1978-03-24 |
1985-07-16 |
The Regents Of The University Of California |
Method for producing liposomes in selected size range
|
US4186183A
(en)
|
1978-03-29 |
1980-01-29 |
The United States Of America As Represented By The Secretary Of The Army |
Liposome carriers in chemotherapy of leishmaniasis
|
US4298594A
(en)
|
1978-04-14 |
1981-11-03 |
Arthur D. Little, Inc. |
Xenobiotic delivery vehicles, method of forming them and method of using them
|
GB2026340B
(en)
|
1978-07-03 |
1982-12-22 |
Ash P |
Stabilising microvesicles
|
DE2965725D1
(en)
|
1978-07-19 |
1983-07-28 |
Patrick Couvreur |
Biodegradable nanoparticles, pharmaceutical compositions containing them and process for their preparation
|
US4219548A
(en)
|
1978-09-01 |
1980-08-26 |
The Procter & Gamble Company |
Topical anti-inflammatory composition
|
US4369182A
(en)
|
1978-09-27 |
1983-01-18 |
A. Nattermann & Cie Gmbh |
Inflammation-preventing pharmaceutical composition of oral administration
|
DE2856333C2
(de)
|
1978-12-27 |
1983-09-22 |
A. Nattermann & Cie GmbH, 5000 Köln |
Oral einnehmbare Arzneimittel mit entzündungshemmender Wirkung
|
IT1111367B
(it)
|
1978-11-17 |
1986-01-13 |
Serono Ist Farm |
Processo per la preparazione estemporanea di liposomi e liposomi cosi' ottenuti
|
US4328222A
(en)
|
1978-11-21 |
1982-05-04 |
Hoffmann-La Roche Inc. |
Pharmaceutical compositions for parenteral or local administration
|
GR73668B
(xx)
|
1978-11-21 |
1984-03-28 |
Hoffmann La Roche |
|
US4241046A
(en)
|
1978-11-30 |
1980-12-23 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
US4421747A
(en)
|
1978-12-27 |
1983-12-20 |
A. Nattermann & Cie. Gmbh |
Inflammation-preventing pharmaceutical composition of oral administration
|
US4378354A
(en)
|
1978-12-27 |
1983-03-29 |
A. Nattermann & Cie. Gmbh |
Inflammation-preventing pharmaceutical composition of oral administration
|
US4316884A
(en)
|
1979-01-25 |
1982-02-23 |
Adria Laboratories, Inc. |
Sustained release pharmaceutical formulation
|
DE2914788A1
(de)
|
1979-04-11 |
1980-10-16 |
Nattermann A & Cie |
Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
|
US4345588A
(en)
|
1979-04-23 |
1982-08-24 |
Northwestern University |
Method of delivering a therapeutic agent to a target capillary bed
|
JPS6030652B2
(ja)
|
1979-05-07 |
1985-07-17 |
株式会社ミドリ十字 |
静脈注射用脂肪乳剤
|
US4294916A
(en)
|
1979-05-22 |
1981-10-13 |
Ciba-Geigy Ag |
Photographic silver halide material containing a dye filter or a dye anti-halation layer
|
US4231938A
(en)
|
1979-06-15 |
1980-11-04 |
Merck & Co., Inc. |
Hypocholesteremic fermentation products and process of preparation
|
JPS562353A
(en)
|
1979-06-20 |
1981-01-12 |
Ricoh Co Ltd |
Novel disazo compound and its preparation
|
CA1173360A
(en)
|
1979-06-22 |
1984-08-28 |
Jurg Schrank |
Pharmaceutical preparations
|
US4309404A
(en)
*
|
1979-08-09 |
1982-01-05 |
American Home Products Corporation |
Sustained release pharmaceutical compositions
|
US4543370A
(en)
|
1979-11-29 |
1985-09-24 |
Colorcon, Inc. |
Dry edible film coating composition, method and coating form
|
DE3003886A1
(de)
*
|
1980-02-02 |
1981-08-13 |
Olympia Werke Ag, 2940 Wilhelmshaven |
Farbbandkassette fuer eine schreib- o.ae. bueromaschine
|
AR220263A1
(es)
|
1980-02-19 |
1980-10-15 |
Bago Lab Sa |
Procedimiento para obtener una preparacion inyectable de sulfonamida potenciada de baja irritabilidad
|
US4302459A
(en)
|
1980-03-19 |
1981-11-24 |
The United States Of America As Represented By The Secretary Of The Army |
Liposome carriers in leishmaniasis chemotherapy with 8-aminoquinoline derivatives
|
JPS56152739A
(en)
|
1980-04-25 |
1981-11-26 |
Tanabe Seiyaku Co Ltd |
Production of microcapsule
|
US4475919A
(en)
|
1980-04-28 |
1984-10-09 |
Colorcon, Inc. |
Colored medicinal tablet, natural color pigment and method for using the pigment in coloring food, drug and cosmetic products
|
JPS609726B2
(ja)
|
1980-05-15 |
1985-03-12 |
株式会社 ミドリ十字 |
ステロイド製剤
|
JPS6222729Y2
(xx)
|
1980-06-04 |
1987-06-10 |
|
|
DK149080C
(da)
|
1980-06-06 |
1986-07-28 |
Sankyo Co |
Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
|
US4331654A
(en)
|
1980-06-13 |
1982-05-25 |
Eli Lilly And Company |
Magnetically-localizable, biodegradable lipid microspheres
|
DE3024416C2
(de)
|
1980-06-28 |
1982-04-15 |
Gödecke AG, 1000 Berlin |
Verfahren zur Herstellung von Arzneimitteln mit retardierter Wirkstoff-Freisetzung
|
US4450171A
(en)
|
1980-08-05 |
1984-05-22 |
Merck & Co., Inc. |
Antihypercholesterolemic compounds
|
US4683256A
(en)
|
1980-11-06 |
1987-07-28 |
Colorcon, Inc. |
Dry edible film coating composition, method and coating form
|
DE3169595D1
(en)
|
1980-11-10 |
1985-05-02 |
Gersonde Klaus |
Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application
|
US4394372A
(en)
|
1980-12-22 |
1983-07-19 |
The Procter & Gamble Company |
Process for making lipid membrane structures
|
US4432975A
(en)
*
|
1981-04-13 |
1984-02-21 |
Icn Pharmaceuticals, Inc. |
Process for introducing vitamin B-12 into the bloodstream
|
US4397846A
(en)
|
1981-05-15 |
1983-08-09 |
Murray Weiner |
Storage-stable lipid vesicles and method of preparation
|
IE53696B1
(en)
|
1981-12-02 |
1989-01-18 |
Wyeth John & Brother Ltd |
Solid shaped articles
|
US4448784A
(en)
|
1982-04-12 |
1984-05-15 |
Hoechst-Roussel Pharmaceuticals, Inc. |
1-(Aminoalkylphenyl and aminoalkylbenzyl)-indoles and indolines and analgesic method of use thereof
|
US4485054A
(en)
|
1982-10-04 |
1984-11-27 |
Lipoderm Pharmaceuticals Limited |
Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
|
US4739073A
(en)
|
1983-11-04 |
1988-04-19 |
Sandoz Pharmaceuticals Corp. |
Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
|
HU204253B
(en)
|
1982-11-22 |
1991-12-30 |
Sandoz Ag |
Process for producing mevalonolactone analogues and derivatives and pharmaceutical compositions containing them
|
US5030453A
(en)
|
1983-03-24 |
1991-07-09 |
The Liposome Company, Inc. |
Stable plurilamellar vesicles
|
US4515736A
(en)
|
1983-05-12 |
1985-05-07 |
The Regents Of The University Of California |
Method for encapsulating materials into liposomes
|
US4622219A
(en)
|
1983-06-17 |
1986-11-11 |
Haynes Duncan H |
Method of inducing local anesthesia using microdroplets of a general anesthetic
|
US4725442A
(en)
|
1983-06-17 |
1988-02-16 |
Haynes Duncan H |
Microdroplets of water-insoluble drugs and injectable formulations containing same
|
JPS601122A
(ja)
|
1983-06-20 |
1985-01-07 |
Green Cross Corp:The |
ビフエニリルプロピオン酸誘導体脂肪乳剤
|
JPS606619A
(ja)
|
1983-06-27 |
1985-01-14 |
Kyowa Chem Ind Co Ltd |
鉄分欠乏症処置剤及びその製法
|
US4704295A
(en)
|
1983-09-19 |
1987-11-03 |
Colorcon, Inc. |
Enteric film-coating compositions
|
US4492720A
(en)
|
1983-11-15 |
1985-01-08 |
Benjamin Mosier |
Method of preparing microspheres for intravascular delivery
|
US4532089A
(en)
|
1984-01-14 |
1985-07-30 |
Northwestern University |
Method of preparing giant size liposomes
|
JPS60174726A
(ja)
|
1984-02-21 |
1985-09-09 |
Nippon Shinyaku Co Ltd |
注射用医薬組成物
|
US4610868A
(en)
|
1984-03-20 |
1986-09-09 |
The Liposome Company, Inc. |
Lipid matrix carriers for use in drug delivery systems
|
JPS60208910A
(ja)
|
1984-03-31 |
1985-10-21 |
Green Cross Corp:The |
水難溶性薬物・リン脂質複合体の製造方法
|
US4963367A
(en)
|
1984-04-27 |
1990-10-16 |
Medaphore, Inc. |
Drug delivery compositions and methods
|
DE3421468A1
(de)
|
1984-06-08 |
1985-12-19 |
Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim |
Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
|
US4643894A
(en)
|
1984-07-24 |
1987-02-17 |
Colorcon, Inc. |
Maltodextrin coating
|
US4828841A
(en)
|
1984-07-24 |
1989-05-09 |
Colorcon, Inc. |
Maltodextrin coating
|
JPS6176414A
(ja)
|
1984-09-21 |
1986-04-18 |
Shionogi & Co Ltd |
リポソーム製剤の製法
|
US4761288A
(en)
|
1984-09-24 |
1988-08-02 |
Mezei Associates Limited |
Multiphase liposomal drug delivery system
|
JPS61174940A
(ja)
|
1985-01-29 |
1986-08-06 |
Oogawara Kakoki Kk |
ワックス類コーテイング単核状マイクロカプセルおよびその製造方法
|
US4727077A
(en)
|
1985-02-20 |
1988-02-23 |
Ishihara Sangyo Kaisha Ltd. |
Benzoyl urea compounds, process for their production, and antitumorous compositions containing them
|
US4693912A
(en)
|
1985-02-28 |
1987-09-15 |
Technicon Instruments Corporation |
Lyophilization of reagent-coated particles
|
JPH0688911B2
(ja)
|
1985-06-06 |
1994-11-09 |
国立予防衛生研究所長 |
インフルエンザワクチン及びその製造方法
|
JPS6222729A
(ja)
*
|
1985-07-23 |
1987-01-30 |
Kao Corp |
易崩壊性錠剤
|
US4766046A
(en)
|
1985-09-27 |
1988-08-23 |
Liposome Technology, Inc. |
Stabilized liposome/amphotericin composition and method
|
JPH0617309B2
(ja)
|
1985-11-29 |
1994-03-09 |
株式会社ビタミン研究所 |
アドリアマイシン包埋リポソ−ム製剤
|
US4803070A
(en)
|
1986-04-15 |
1989-02-07 |
Ribi Immunochem Research Inc. |
Immunological emulsion adjuvants for polysaccharide vaccines
|
US4806352A
(en)
|
1986-04-15 |
1989-02-21 |
Ribi Immunochem Research Inc. |
Immunological lipid emulsion adjuvant
|
US4806350A
(en)
|
1986-04-18 |
1989-02-21 |
Norden Laboratories, Inc. |
Vaccine formulation
|
US4802924A
(en)
|
1986-06-19 |
1989-02-07 |
Colorcon, Inc. |
Coatings based on polydextrose for aqueous film coating of pharmaceutical food and confectionary products
|
US5116870A
(en)
|
1986-06-23 |
1992-05-26 |
Merck & Co., Inc. |
HMG-CoA reductase inhibitors
|
US4940727A
(en)
|
1986-06-23 |
1990-07-10 |
Merck & Co., Inc. |
Novel HMG-CoA reductase inhibitors
|
DE3623376A1
(de)
|
1986-07-11 |
1988-01-21 |
Behringwerke Ag |
Pharmazeutische formulierung und verfahren zu deren herstellung
|
FR2602423B1
(fr)
|
1986-08-08 |
1989-05-05 |
Ethypharm Sa |
Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
|
US4776991A
(en)
|
1986-08-29 |
1988-10-11 |
The United States Of America As Represented By The Secretary Of The Navy |
Scaled-up production of liposome-encapsulated hemoglobin
|
CA1338736C
(fr)
|
1986-12-05 |
1996-11-26 |
Roger Baurain |
Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation
|
DK175531B1
(da)
|
1986-12-15 |
2004-11-22 |
Nexstar Pharmaceuticals Inc |
Leveringsvehikel med amphiphil-associeret aktiv bestanddel
|
US5320906A
(en)
|
1986-12-15 |
1994-06-14 |
Vestar, Inc. |
Delivery vehicles with amphiphile-associated active ingredient
|
US5179079A
(en)
|
1986-12-16 |
1993-01-12 |
Novo Nordisk A/S |
Nasal formulation and intranasal administration therewith
|
US4837028A
(en)
*
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
US4839111A
(en)
|
1987-02-02 |
1989-06-13 |
The University Of Tennessee Research Corporation |
Preparation of solid core liposomes
|
US5154930A
(en)
*
|
1987-03-05 |
1992-10-13 |
The Liposome Company, Inc. |
Pharmacological agent-lipid solution preparation
|
US4904646A
(en)
|
1987-05-22 |
1990-02-27 |
E. R. Squibb & Sons, Inc. |
Phosphorus-containing HMG-COA reductase inhibitors
|
US5017716A
(en)
|
1987-05-22 |
1991-05-21 |
E.R. Squibb & Sons, Inc. |
Phosphorous-containing HMG-CoA reductase inhibitors, new intermediates and method
|
US5091378A
(en)
|
1987-05-22 |
1992-02-25 |
E. R. Squibb & Sons, Inc. |
Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method
|
FR2617047B1
(fr)
|
1987-06-23 |
1991-05-10 |
Sanofi Sa |
Composition de gelatine resistant au tannage, capsules a base de cette composition et leur application pharmaceutique, notamment au fenofibrate
|
CA1336714C
(en)
|
1987-08-20 |
1995-08-15 |
Yoshihiro Fujikawa |
Quinoline type mevalonolactone inhibitors of cholesterol biosynthesis
|
US4997837A
(en)
|
1987-09-08 |
1991-03-05 |
Warner-Lambert Company |
6-(((substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
|
US4906624A
(en)
|
1987-09-08 |
1990-03-06 |
Warner-Lambert Company |
6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
|
US4929620A
(en)
|
1987-12-10 |
1990-05-29 |
Warner-Lambert Company |
5-pyrimidinyl-3,5-dihydroxy-6-heptenoic acid compounds useful as inhibitors of cholesterol biosynthesis
|
US5001144A
(en)
|
1987-12-21 |
1991-03-19 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Substituted cyclohexene derivatives as HMG-CoA reductase inhibitors
|
US4939143A
(en)
|
1987-12-21 |
1990-07-03 |
Rorer Pharmaceutical Corporation |
Substituted cyclohexene derivatives as HMG-CoA reductase inhibitors
|
US4900754A
(en)
|
1987-12-21 |
1990-02-13 |
Rorer Pharmaceutical Corp. |
HMG-COA reductase inhibitors
|
US5001128A
(en)
|
1987-12-21 |
1991-03-19 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
HMG-COA reductase inhibitors
|
US4994494A
(en)
|
1987-12-21 |
1991-02-19 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
HMG-COA reductase inhibitors
|
US5360593A
(en)
|
1987-12-29 |
1994-11-01 |
Alcon Laboratories, Inc. |
Heat sterilization of labile antibiotics
|
ES2033086T3
(es)
|
1988-01-29 |
1993-03-01 |
Sankyo Company Limited |
Un procedimiento para la preparacion de una composicion farmaceutica.
|
US4946864A
(en)
|
1988-02-01 |
1990-08-07 |
Merck & Co., Inc. |
Novel HMG-CoA reductase inhibitors
|
FR2627696B1
(fr)
|
1988-02-26 |
1991-09-13 |
Fournier Innovation Synergie |
Nouvelle forme galenique du fenofibrate
|
EP0331250B1
(en)
|
1988-03-02 |
1994-04-13 |
Merck & Co. Inc. |
Antihypercholesterolemic agents
|
US5021453A
(en)
|
1988-03-02 |
1991-06-04 |
Merck & Co., Inc. |
3-keto HMG-CoA reductase inhibitors
|
US4920109A
(en)
|
1988-04-18 |
1990-04-24 |
Merck & Co., Inc. |
Antifungal compositions and method of controlling mycotic infections
|
US5006362A
(en)
|
1988-05-09 |
1991-04-09 |
Berwind Pharmaceutical Services, Inc. |
Branding pharmaceutical dosage forms, food and confectionery products with aqueous ingestible inks
|
US5744477A
(en)
*
|
1988-05-10 |
1998-04-28 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Method for treatment of obesity using prolactin modulators and diet
|
US5166171A
(en)
|
1988-05-13 |
1992-11-24 |
Hoechst Aktiengesellschaft |
6-phenoxymethyl-4-hydroxytetrahydropyran-2-ones and 6-thiphenoxymethyl-4-hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters, and in treating hypercholesterolemia
|
US5217707A
(en)
|
1988-06-16 |
1993-06-08 |
Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. |
Pharmaceutical composition and process for the preparation thereof
|
US4897402A
(en)
|
1988-06-29 |
1990-01-30 |
Merck & Co., Inc. |
5-oxa, 5-thia, 5-aza HmG-CoA reductase inhibitors
|
US4963538A
(en)
|
1988-06-29 |
1990-10-16 |
Merck & Co., Inc. |
5-oxygenated HMG-CoA reductase inhibitors
|
IT1226726B
(it)
|
1988-07-29 |
1991-02-05 |
Zambon Spa |
Composti attivi come inibitori della biosintesi del colesterolo.
|
US5196440A
(en)
|
1988-07-29 |
1993-03-23 |
Zambon Group S.P.A. |
Compounds active as inhibitors of the cholesterol biosynthesis
|
US5342625A
(en)
*
|
1988-09-16 |
1994-08-30 |
Sandoz Ltd. |
Pharmaceutical compositions comprising cyclosporins
|
DE3832570A1
(de)
|
1988-09-24 |
1990-03-29 |
Hoechst Ag |
7-substituierte derivate der 3,5-dihydroxyhept-6-insaeure, verfahren zur ihrer herstellung, ihre verwendung als arzneimittel, sowie zwischenprodukte
|
GB8822857D0
(en)
|
1988-09-29 |
1988-11-02 |
Patralan Ltd |
Pharmaceutical formulations
|
US4906657A
(en)
|
1988-12-21 |
1990-03-06 |
Warner-Lambert Company |
Bicyclo heptane and bicyclo octane substituted inhibitors of cholesterol synthesis
|
US4957940A
(en)
|
1988-12-21 |
1990-09-18 |
Warner-Lambert Company |
Bicyclo heptane and bicyclo octane substituted inhibitors of cholesterol synthesis
|
US4950675A
(en)
|
1988-12-21 |
1990-08-21 |
Warner-Lambert Company |
Pyridine di-mevalono-lactones as inhibitors of cholesterol biosynthesis
|
DE3903057A1
(de)
|
1989-02-02 |
1990-08-09 |
Braun Melsungen Ag |
Fettemulsion zur endotrachealen applikation, ihre herstellung und anwendung
|
DE3903056A1
(de)
|
1989-02-02 |
1990-08-09 |
Braun Melsungen Ag |
Fettemulsion zur intraperitonealen applikation, ihre herstellung und anwendung
|
US4923861A
(en)
|
1989-02-07 |
1990-05-08 |
Warner-Lambert Company |
6-(2-(2-(Substituted amino)-3-quinolinyl) ethenyl and ethyl) tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
|
US5130306A
(en)
|
1989-03-13 |
1992-07-14 |
Merck & Co., Inc. |
5-Oxygenated HMG-COA reductase inhibitors
|
US5132312A
(en)
|
1989-03-27 |
1992-07-21 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Substituted cyclohexene derivatives as HMG-CoA reductase inhibitors
|
AU614465B2
(en)
|
1989-04-05 |
1991-08-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Medicinal emulsions
|
US4970231A
(en)
|
1989-06-09 |
1990-11-13 |
Merck & Co., Inc. |
4-substituted HMG-CoA reductase inhibitors
|
US5102911A
(en)
|
1989-06-09 |
1992-04-07 |
Merck & Co, Inc. |
4-Substituted HMG-CoA reductase inhibitors
|
FI94339C
(fi)
|
1989-07-21 |
1995-08-25 |
Warner Lambert Co |
Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
|
US4992429A
(en)
|
1989-08-24 |
1991-02-12 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Novel HMG-COA reductase inhibitors
|
US5098931A
(en)
|
1989-08-31 |
1992-03-24 |
Merck & Co., Inc. |
7-substituted HMG-CoA reductase inhibitors
|
FR2651680B1
(fr)
|
1989-09-14 |
1991-12-27 |
Medgenix Group Sa |
Nouveau procede de preparation de microparticules lipidiques.
|
US5178878A
(en)
|
1989-10-02 |
1993-01-12 |
Cima Labs, Inc. |
Effervescent dosage form with microparticles
|
US4946860A
(en)
|
1989-11-03 |
1990-08-07 |
Rorer Pharmaceutical Corporation |
Benzothiopyranyl derivatives as HMG-CoA reductase inhibitors
|
JP2785981B2
(ja)
*
|
1989-11-20 |
1998-08-13 |
株式会社資生堂 |
乳化組成物
|
IT1237793B
(it)
|
1989-12-21 |
1993-06-17 |
Zambon Spa |
Composti attivi come inibitori dell'enzima hmg-coa reduttasi
|
US5389377A
(en)
|
1989-12-22 |
1995-02-14 |
Molecular Bioquest, Inc. |
Solid care therapeutic compositions and methods for making same
|
US5025000A
(en)
|
1990-03-02 |
1991-06-18 |
E. R. Squibb & Sons, Inc. |
Phosphorus-containing HMG-CoA reductase inhibitor compounds
|
IT1241088B
(it)
*
|
1990-03-27 |
1993-12-29 |
Chiesi Farma Spa |
Procedimento per la preparazione di complessi piroxicam/ciclodestrina,prodotti ottenuti e loro composizioni farmaceutiche
|
WO1991015548A1
(en)
|
1990-04-04 |
1991-10-17 |
Berwind Pharmaceutical Services, Inc. |
Aqueous maltodextrin and cellulosic polymer film coatings
|
US5246707A
(en)
|
1990-04-26 |
1993-09-21 |
Haynes Duncan H |
Sustained release delivery of water-soluble bio-molecules and drugs using phospholipid-coated microcrystals, microdroplets and high-concentration liposomes
|
US5091188A
(en)
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
US5091187A
(en)
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
CA2039763A1
(en)
|
1990-04-30 |
1991-10-31 |
Henry Y. Pan |
Combination of pravastatin and a fibric acid derivative, and method for treating dyslipidemia using such combination
|
US5298497A
(en)
*
|
1990-05-15 |
1994-03-29 |
E. R. Squibb & Sons, Inc. |
Method for preventing onset of hypertension employing a cholesterol lowering drug
|
US5622985A
(en)
|
1990-06-11 |
1997-04-22 |
Bristol-Myers Squibb Company |
Method for preventing a second heart attack employing an HMG CoA reductase inhibitor
|
CA2048395A1
(en)
|
1990-08-23 |
1992-02-24 |
Henry Y. Pan |
Method for preventing onset of or treating type iii hyperlipoproteinemia employing pravastatin
|
US5112857A
(en)
|
1990-09-04 |
1992-05-12 |
Merck & Co., Inc. |
Hmg-coa reductase inhibitor metabolites
|
HU205550B
(en)
|
1990-11-27 |
1992-05-28 |
Egyt Gyogyszervegyeszeti Gyar |
Process for producing pyroxycam solution of increased stability, free from effects damaging tussues
|
HU211580A9
(hu)
|
1990-11-27 |
1995-12-28 |
Egyt Gyogyszervegyeszeti Gyar |
Megnövelt stabilitású, szövetkárosító hatás nélküli piroxikam-oldatok Az átmeneti oltalom az 1., 2., 5. és 6. igénypontokra vonatkozik.
|
US5399363A
(en)
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
US5552160A
(en)
|
1991-01-25 |
1996-09-03 |
Nanosystems L.L.C. |
Surface modified NSAID nanoparticles
|
US5182298A
(en)
|
1991-03-18 |
1993-01-26 |
Merck & Co., Inc. |
Cholesterol lowering agents
|
MX9201782A
(es)
|
1991-04-19 |
1992-10-01 |
Sandoz Ag |
Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene.
|
US5256689A
(en)
|
1991-05-10 |
1993-10-26 |
Merck & Co., Inc. |
Cholesterol lowering compounds
|
US5135935A
(en)
|
1991-05-17 |
1992-08-04 |
Merck & Co., Inc. |
Squalene synthetase inhibitors
|
US5250435A
(en)
|
1991-06-04 |
1993-10-05 |
Merck & Co., Inc. |
Mutant strains of Aspergillus terreus for producing 7-[1,2,6,7,8,8a(R)-hexa-hydro-2(S),6(R)-dimethyl-8(S)-hydroxy-1(S)-naphthyl]-3(R),5(R)-dihydroxyheptanoic acid (triol acid),I)
|
US5202327A
(en)
|
1991-07-10 |
1993-04-13 |
E. R. Squibb & Sons, Inc. |
Phosphorus-containing hmg-coa reductase inhibitors
|
DE4131562A1
(de)
|
1991-09-18 |
1993-03-25 |
Medac Klinische Spezialpraep |
Arzneistofftraeger aus festen lipidteilchen-feste lipidnanosphaeren (sln)
|
DE4140192C2
(de)
|
1991-12-05 |
1996-02-29 |
Alfatec Pharma Gmbh |
Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen
|
HU9203780D0
(en)
|
1991-12-12 |
1993-03-29 |
Sandoz Ag |
Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
|
JP3059559B2
(ja)
|
1991-12-17 |
2000-07-04 |
日本バイエルアグロケム株式会社 |
殺虫性グアニジン誘導体
|
US5260332A
(en)
|
1992-02-07 |
1993-11-09 |
Merci & Co., Inc. |
Cholesterol lowering compounds
|
US5262435A
(en)
|
1992-02-10 |
1993-11-16 |
Merck & Co., Inc. |
Cholesterol lowering compounds
|
US5272137A
(en)
|
1992-02-14 |
1993-12-21 |
Mcneil-Pfc, Inc. |
Aqueous pharmaceutical suspension for pharmaceutical actives
|
US5286895A
(en)
|
1992-02-19 |
1994-02-15 |
Merck & Co., Inc. |
Cholesterol lowering compounds
|
US5302604A
(en)
|
1992-03-09 |
1994-04-12 |
Merck & Co., Inc. |
Cholesterol lowering compounds produced by directed biosynthesis
|
EP0570829B1
(de)
|
1992-05-18 |
2001-04-25 |
CicloMulsion AG |
Cyclosporin(e) enthaltende pharmazeutische Zubereitung zur intravenösen Applikation sowie Verfahren zu ihrer Herstellung
|
US5369125A
(en)
|
1992-07-17 |
1994-11-29 |
Merck & Co., Inc. |
Cholesterol-lowering agents
|
US5283256A
(en)
|
1992-07-22 |
1994-02-01 |
Merck & Co., Inc. |
Cholesterol-lowering agents
|
US5317031A
(en)
|
1992-10-19 |
1994-05-31 |
Merck & Co., Inc. |
Cholesterol lowering compounds
|
US5298262A
(en)
|
1992-12-04 |
1994-03-29 |
Sterling Winthrop Inc. |
Use of ionic cloud point modifiers to prevent particle aggregation during sterilization
|
US5346702A
(en)
|
1992-12-04 |
1994-09-13 |
Sterling Winthrop Inc. |
Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization
|
US5302401A
(en)
|
1992-12-09 |
1994-04-12 |
Sterling Winthrop Inc. |
Method to reduce particle size growth during lyophilization
|
US5340564A
(en)
|
1992-12-10 |
1994-08-23 |
Sterling Winthrop Inc. |
Formulations comprising olin 10-G to prevent particle aggregation and increase stability
|
US5336507A
(en)
|
1992-12-11 |
1994-08-09 |
Sterling Winthrop Inc. |
Use of charged phospholipids to reduce nanoparticle aggregation
|
US5352459A
(en)
|
1992-12-16 |
1994-10-04 |
Sterling Winthrop Inc. |
Use of purified surface modifiers to prevent particle aggregation during sterilization
|
US5326552A
(en)
|
1992-12-17 |
1994-07-05 |
Sterling Winthrop Inc. |
Formulations for nanoparticulate x-ray blood pool contrast agents using high molecular weight nonionic surfactants
|
US5785976A
(en)
|
1993-03-05 |
1998-07-28 |
Pharmacia & Upjohn Ab |
Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
|
CA2091152C
(en)
|
1993-03-05 |
2005-05-03 |
Kirsten Westesen |
Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
|
US5576016A
(en)
|
1993-05-18 |
1996-11-19 |
Pharmos Corporation |
Solid fat nanoemulsions as drug delivery vehicles
|
CH686761A5
(de)
|
1993-05-27 |
1996-06-28 |
Sandoz Ag |
Galenische Formulierungen.
|
US5639474A
(en)
|
1993-07-01 |
1997-06-17 |
Hanmi Pharm. Ind., Ltd. |
Cyclosporin soft capsule composition
|
CA2166891C
(en)
*
|
1993-07-09 |
2001-07-03 |
Sang K. Wong |
Method for making freeze dried drug dosage forms
|
DE4323636A1
(de)
|
1993-07-15 |
1995-01-19 |
Hoechst Ag |
Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
DE4329446A1
(de)
|
1993-09-01 |
1995-03-02 |
Basf Ag |
Verfahren zur Herstellung von feinteiligen Farb- oder Wirkstoffzubereitungen
|
JPH09504293A
(ja)
*
|
1993-10-28 |
1997-04-28 |
ザ、プロクター、エンド、ギャンブル、カンパニー |
マグネシウムアルミニウムシリケート及び複数の活性成分を含有した速溶解性剤形
|
US5567592A
(en)
*
|
1994-02-02 |
1996-10-22 |
Regents Of The University Of California |
Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
|
US5635210A
(en)
|
1994-02-03 |
1997-06-03 |
The Board Of Regents Of The University Of Oklahoma |
Method of making a rapidly dissolving tablet
|
HUT74735A
(en)
*
|
1994-02-25 |
1997-02-28 |
Takeda Chemical Industries Ltd |
Injectable emulsion composition containing antifungal triazole derivatives and process for producing it
|
US5364633A
(en)
|
1994-03-14 |
1994-11-15 |
Dow Corning Corporation |
Silicone vesicles and entrapment
|
GB9405304D0
(en)
|
1994-03-16 |
1994-04-27 |
Scherer Ltd R P |
Delivery systems for hydrophobic drugs
|
CA2185810A1
(en)
|
1994-03-28 |
1995-10-05 |
Jo Klaveness |
Liposomes
|
GB9409778D0
(en)
*
|
1994-05-16 |
1994-07-06 |
Dumex Ltd As |
Compositions
|
FR2722984B1
(fr)
|
1994-07-26 |
1996-10-18 |
Effik Lab |
Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
|
GB9421836D0
(en)
*
|
1994-10-28 |
1994-12-14 |
Scherer Corp R P |
Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
|
US5858398A
(en)
|
1994-11-03 |
1999-01-12 |
Isomed Inc. |
Microparticular pharmaceutical compositions
|
US5603951A
(en)
|
1994-11-09 |
1997-02-18 |
Hanmi Pharm. Ind. Co., Ltd. |
Cyclosporin-containing soft capsule compositions
|
DE4440337A1
(de)
|
1994-11-11 |
1996-05-15 |
Dds Drug Delivery Services Ges |
Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
|
US5660854A
(en)
|
1994-11-28 |
1997-08-26 |
Haynes; Duncan H |
Drug releasing surgical implant or dressing material
|
KR0167613B1
(ko)
|
1994-12-28 |
1999-01-15 |
한스 루돌프 하우스, 니콜 케르커 |
사이클로스포린-함유 연질캅셀제 조성물
|
US5545628A
(en)
|
1995-01-10 |
1996-08-13 |
Galephar P.R. Inc. |
Pharmaceutical composition containing fenofibrate
|
US5569448A
(en)
|
1995-01-24 |
1996-10-29 |
Nano Systems L.L.C. |
Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions
|
FR2730231B1
(fr)
|
1995-02-02 |
1997-04-04 |
Fournier Sca Lab |
Association de fenofibrate et de vitamine e, utilisation en therapeutique
|
US5571536A
(en)
|
1995-02-06 |
1996-11-05 |
Nano Systems L.L.C. |
Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
|
US5560931A
(en)
|
1995-02-14 |
1996-10-01 |
Nawosystems L.L.C. |
Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
|
US5510118A
(en)
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
SI9500173B
(sl)
|
1995-05-19 |
2002-02-28 |
Lek, |
Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo
|
US5716928A
(en)
*
|
1995-06-07 |
1998-02-10 |
Avmax, Inc. |
Use of essential oils to increase bioavailability of oral pharmaceutical compounds
|
FR2737121B1
(fr)
|
1995-07-27 |
1997-10-03 |
Cl Pharma |
Nouvelles formulations galeniques du fenofibrate et leurs applications
|
US5827822A
(en)
|
1996-03-25 |
1998-10-27 |
Sangstat Medical Corporation |
Cyclosporin a formulations as nanoparticles
|
US5834025A
(en)
|
1995-09-29 |
1998-11-10 |
Nanosystems L.L.C. |
Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
|
CZ288631B6
(cs)
|
1996-01-18 |
2001-08-15 |
Galena, A. S. |
Léčivé přípravky s obsahem cyklosporinu
|
US5686133A
(en)
|
1996-01-31 |
1997-11-11 |
Port Systems, L.L.C. |
Water soluble pharmaceutical coating and method for producing coated pharmaceuticals
|
DE19608750A1
(de)
|
1996-03-06 |
1997-09-11 |
Durachemie Gmbh & Co Kg |
Verfahren zur Herstellung von Fenofibrat-Präparaten
|
AU1939797A
(en)
*
|
1996-03-14 |
1997-10-01 |
Shionogi & Co., Ltd. |
Rapid-release microdispersible ecadotril preparation
|
US5637625A
(en)
|
1996-03-19 |
1997-06-10 |
Research Triangle Pharmaceuticals Ltd. |
Propofol microdroplet formulations
|
US5660858A
(en)
|
1996-04-03 |
1997-08-26 |
Research Triangle Pharmaceuticals |
Cyclosporin emulsions
|
EP0893992B1
(en)
*
|
1996-04-16 |
2004-03-03 |
Novartis Consumer Health S.A. |
Fast disintegrating oral dosage form
|
DE69728206T2
(de)
|
1996-05-14 |
2005-03-10 |
Dsm Ip Assets B.V. |
Herstellungsverfahren für Carotenoid-Zusammensetzungen
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
KR100542816B1
(ko)
*
|
1996-08-22 |
2006-01-11 |
알티피 파마 코포레이션 |
수불용성 물질의 미립자를 포함하는 조성물 및 이것의 제조 방법
|
US6465016B2
(en)
*
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US5891469A
(en)
*
|
1997-04-02 |
1999-04-06 |
Pharmos Corporation |
Solid Coprecipitates for enhanced bioavailability of lipophilic substances
|
US5807580A
(en)
|
1996-10-30 |
1998-09-15 |
Mcneil-Ppc, Inc. |
Film coated tablet compositions having enhanced disintegration characteristics
|
US5919776A
(en)
*
|
1996-12-20 |
1999-07-06 |
Merck & Co., Inc. |
Substituted aminoquinolines as modulators of chemokine receptor activity
|
FR2758459B1
(fr)
|
1997-01-17 |
1999-05-07 |
Pharma Pass |
Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
|
US6045829A
(en)
|
1997-02-13 |
2000-04-04 |
Elan Pharma International Limited |
Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
|
US5976577A
(en)
*
|
1997-07-11 |
1999-11-02 |
Rp Scherer Corporation |
Process for preparing fast dispersing solid oral dosage form
|
US6180660B1
(en)
*
|
1997-08-26 |
2001-01-30 |
Merck & Co., Inc. |
Cholesterol-lowering therapy
|
CA2214895C
(en)
|
1997-09-19 |
1999-04-20 |
Bernard Charles Sherman |
Improved pharmaceutical composition comprising fenofibrate
|
US6027747A
(en)
|
1997-11-11 |
2000-02-22 |
Terracol; Didier |
Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions
|
US5891845A
(en)
*
|
1997-11-21 |
1999-04-06 |
Fuisz Technologies Ltd. |
Drug delivery systems utilizing liquid crystal structures
|
US6063762A
(en)
|
1997-12-05 |
2000-05-16 |
Chong Kun Dang Corp. |
Cyclosporin-containing microemulsion preconcentrate composition
|
PL197989B1
(pl)
*
|
1997-12-19 |
2008-05-30 |
Smithkline Beecham Corp |
Sposób wytwarzania szybko rozpraszających się tabletek do podawania doustnego, szybko rozpraszający się preparat farmaceutyczny w postaci tabletek i szybko rozpraszająca się, farmaceutycznie dopuszczalna, tabletka do podawania doustnego
|
US6086376A
(en)
|
1998-01-30 |
2000-07-11 |
Rtp Pharma Inc. |
Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
|
FR2776191B1
(fr)
*
|
1998-03-23 |
2002-05-31 |
Theramex |
Composition hormonale topique a effet systemique
|
US6337092B1
(en)
|
1998-03-30 |
2002-01-08 |
Rtp Pharma Inc. |
Composition and method of preparing microparticles of water-insoluble substances
|
KR100628341B1
(ko)
|
1998-03-30 |
2006-09-27 |
스키에파마 캐나다 인코포레이티드 |
수-불용성 물질의 미소입자 조성물 및 이의 제조방법
|
AU764001B2
(en)
*
|
1998-05-29 |
2003-08-07 |
Skyepharma Canada Inc. |
Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
US6375986B1
(en)
*
|
2000-09-21 |
2002-04-23 |
Elan Pharma International Ltd. |
Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
|
US6180138B1
(en)
|
1999-01-29 |
2001-01-30 |
Abbott Laboratories |
Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US6270806B1
(en)
|
1999-03-03 |
2001-08-07 |
Elan Pharma International Limited |
Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions
|
US6267989B1
(en)
|
1999-03-08 |
2001-07-31 |
Klan Pharma International Ltd. |
Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions
|
US6057289A
(en)
|
1999-04-30 |
2000-05-02 |
Pharmasolutions, Inc. |
Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
|
US6982281B1
(en)
|
2000-11-17 |
2006-01-03 |
Lipocine Inc |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
CA2407027C
(en)
*
|
2000-04-20 |
2011-02-15 |
Rtp Pharma Inc. |
Improved water-insoluble drug particle process
|
AU5967101A
(en)
*
|
2000-05-10 |
2001-11-20 |
Rtp Pharma Inc |
Media milling
|
US6368628B1
(en)
*
|
2000-05-26 |
2002-04-09 |
Pharma Pass Llc |
Sustained release pharmaceutical composition free of food effect
|
AU2001262945B2
(en)
*
|
2000-09-20 |
2006-02-02 |
Skyepharma Canada Inc. |
Spray drying process and compositions of fenofibrate
|
FR2819720B1
(fr)
|
2001-01-22 |
2004-03-12 |
Fournier Lab Sa |
Nouveaux comprimes de fenofibrate
|
CN1273112C
(zh)
*
|
2001-02-22 |
2006-09-06 |
斯凯伊药品加拿大公司 |
具有减少进食-禁食作用的贝特-它汀组合
|